Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Risk Factors and Severity of Bronchiolitis in Hospitalized Children at Assiut University Hospital
A clinical trial sponsored by Assiut University is examining risk factors and severity of bronchiolitis in hospitalized children. The study …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease [Phase 2]
A Phase 2 study evaluating S-337395 for respiratory syncytial virus in symptomatic nonhospitalized adults at high risk of progression to sev…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women [Phase 1]
Phase 1 study evaluating safety, tolerability, and immunogenicity of MKK900, a maternal respiratory syncytial virus vaccine, in healthy adul…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India [Phase 4]
Phase 4 trial update of Nirsevimab for RSV immunization in children up to 24 months in India; the study is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus [Phase 2]
This is a Phase 2 clinical trial to evaluate the efficacy and safety of Zelicapavir in participants aged 28 days to 36 months with Respirato…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: RSV Burden in Outpatient and Hospital Settings [NA]
A pediatric clinical trial is currently recruiting to assess the burden of respiratory syncytial virus infection in outpatient and hospital …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose [Phase 3]
Pfizer is conducting a Phase 3 trial to evaluate revaccination in subsequent pregnancies using a bivalent RSV vaccine and to determine how l…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay
The completed clinical evaluation studied the VitaSIRO Solo Respiratory Assay for detecting respiratory pathogens, including SARS-CoV-2/COVI…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control [Phase 3]
A Phase 3 follow-up safety study assessing participants who received RSVPreF3 maternal vaccination or controls, with results posted for preg…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Safety of RSV Preventive Monoclonal Antibody [Phase 4]
Phase 4 trial update assessing the safety of an RSV preventive monoclonal antibody. The study is currently recruiting and monitors adverse e…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating an RSV and human metapneumovirus vaccine candidate sponsored by Sanofi Pasteur.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy [Phase 4]
Phase 4 clinical trial evaluating concurrent versus sequential administration of Tdap and an RSV vaccine in pregnant individuals.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Study of Modified mRNA Vaccines in Healthy Adults [Phase 1]
A Phase 1 study of modified mRNA vaccines in healthy adults sponsored by ModernaTX, Inc. has completed, evaluating vaccines targeting COVID-…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older [Phase 2]
Phase 2 study of a Sanofi Pasteur respiratory syncytial virus vaccine candidate in adults aged 60 years and older has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants [Phase 3]
A clinical trial update indicating completion of a Phase 3 study evaluating the efficacy and safety of TNM001 in high-risk infants with Resp…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory
A completed clinical trial evaluated the impact of the 2025 Infant and Maternal RSV Prevention Program on RSV-related hospitalizations in th…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants [Phase 2, Phase 3]
A Phase 2/3 trial evaluating TNM001 for the prevention of lower respiratory tract infections caused by respiratory syncytial virus in infant…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: TARSILA Real-World Evidence Study
The TARSILA real-world evidence study sponsored by Inova Medical is not yet recruiting, investigating respiratory syncytial virus infection …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals [Phase 2]
This entry outlines a Phase 2 clinical trial evaluating remdesivir for upper respiratory tract infection due to respiratory syncytial virus …
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine [Phase 1]
A Phase 1 clinical trial is evaluating the safety of a lyophilized RSV mRNA vaccine, sponsored by Sinovac Biotech, which is not yet recruiti…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants
A clinical trial registry entry describing a research study on the relationship between the gut microbiome and immune response in severe Res…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children [Phase 1]
A Phase 1 trial completed and results posted evaluating infectivity, safety, and immunogenicity of two RSV vaccine candidates, RSV 6120/∆NS1…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older [Phase 2]
A Phase 2 study evaluating the immunogenicity and safety of a recombinant respiratory syncytial virus vaccine in adults aged 60 and older; t…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
VA-sponsored clinical trial update indicates ongoing recruitment to evaluate clinical outcomes and pharmacotherapy effectiveness. The study …
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea [Phase 3]
Pfizer completed a Phase 3 trial in Korea evaluating the safety, tolerability, and immunogenicity of the RSVpreF vaccine in older adults. Re…